SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1321)4/26/1999 9:54:00 AM
From: Jim Roof  Read Replies (1) of 1432
 
The 400m upper limit is old news. BTIM released the piece a couple of weeks back because an ABT rep answered a question poorly which led some to believe that the total potential for Hextend was less than 40m. He was actually speaking only of the total hetastarch market and his figures did not include any impact upon the saline, ringers or albumin market, nor whole blood for that matter.

The lines are pretty much drawn on this stock and it will take actual NEW news to impact the price, not re-iterations, clarifications or 'research reports' from the 'Frito Bandito'.

Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext